Patient-Helpdesk.com

recombinate baxalta patient assistance program

by Freda Johns Published 2 years ago Updated 1 year ago
image

What is the OnePath co-pay assistance program?

The OnePath Co-Pay Assistance Program helps eligible* patients cover certain out-of-pocket treatment costs. † OnePath can also provide assistance with navigating the health insurance process In-home training from a specially trained nurse for you and/or a caregiver on how to self-administer your prescribed Takeda treatment (if appropriate)

How effective is recombinate treatment for hemophilia A?

RECOMBINATE treatment was also effective in stopping bleeding in surgeries (a total of 24 procedures in 13 patients). 1,3 An ongoing study assessed the effectiveness of RECOMBINATE in preventing bleeds in previously untreated patients with hemophilia A.

What is recombinate treatment?

As the first genetically engineered factor VIII concentrate, RECOMBINATE changed the approach to hemophilia A treatment when it was first available in the United States in 1992. 2 RECOMBINATE Treatment 1:

What is baxject II used for?

In the perioperative management of patients with hemophilia A (classical hemophilia) and control of hemorrhagic episodes. Package Insert and Patient Information - 5mL of Sterile Water for Injection using Baxject II Package Insert and Patient Information - 10 mL of Sterile Water for Injection using Baxject II

image

How often is ADVATE given?

ADVATE dosing for routine prophylaxis Use dose of 20 to 40 international units of factor VIII per kg of body weight every other day (3 to 4 times weekly). Alternatively, use every third day dosing regimen targeted to maintain factor VIII trough levels ≥1%. Adjust dose based on the patient's clinical response.

What is the difference between ADVATE and Adynovate?

ADYNOVATE is built on the ADVATE® molecule, a proven treatment in hemophilia A patients. ADYNOVATE was designed to have a longer half-life than ADVATE. This means ADYNOVATE will remain in your body longer to help prevent bleeds. Talk to your healthcare provider to find out what treatment is right for you.

What are Fviii products?

Factor VIII products are used to manage acute bleeding or to prevent excessive bleeding as a treatment for patients with hemophilia A and/or von Willebrand disease.

Who manufactures ADVATE?

Takeda has a variety of resources and programs to help you every step of the way with your treatment on ADVATE.

How is Adynovate given?

Administer ADYNOVATE intravenously over a period of less than or equal to 5 minutes (maximum infusion rate 10 mL per min).

Is Adynovate an extended half-life?

Before beginning prophylactic treatment with ADYNOVATE, a pharmacokinetic comparison of ADYNOVATE vs ADVATE in 26 patients (adolescents and adults 12 years and older) determined that ADYNOVATE has a 40% to 50% extension in half-life, depending on the lab test used.

What are the 13 clotting factors of blood?

What Are The Twelve Blood Clotting Factors?Fibrinogen (Factor 1)Prothrombin (Factor 2)Thromboplastin (Factor 3)Calcium (Factor 4)Proaccelerin or Labile Factor (Factor 5)Stable Factor (Factor 6)Antihemophilic Factor (Factor 8)Christmas Factor (Factor 9)More items...

Is Factor 8 a blood product?

Factor VIII (FVIII) is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene. Defects in this gene result in hemophilia A, a recessive X-linked coagulation disorder.

Is Factor 7 a blood product?

NovoSeven® RT is a genetically engineered (recombinant) version of factor VII. Because it does not contain human blood or plasma, there is no risk of transmitting blood-borne viruses or other pathogens. NovoSeven has been well-tolerated and associated with few side effects.

Is ADVATE the same as Hemlibra?

While Advate requires at least three IV bolus administrations a week, Hemlibra can be given as a weekly subcutaneous injection with better outcomes in annualized bleeding rate and in the proportion of patients experiencing zero bleeds per year.

Can ADVATE be self administered?

Read these instructions before you start infusing with ADVATE or if you need help using the BAXJECT III system. You should not self-infuse unless you have been trained by your healthcare provider or HTC. Read the Instructions for Use before you start using ADVATE.

Is ADVATE a blood product?

In 2003, ADVATE became the first recombinant factor VIII treatment free of blood-based additives. Since then, TAKEDA has made advancements with flexible dosing options, reconstitution with BAXJECT® system, and the introduction of myPKFiT® for PK-guided personalized dosing.

Where is ADVATE manufactured?

1 is produced at the Baxter facility in Hayward, CA, USA and is also used for the purification of the already licensed rFVIII product Recombinate as well as the plasma-derived FVIII product Hemofil.

Who makes Eloctate?

Manufacturer: Biogen Idec, Inc.

Who manufactures Kogenate?

1. Kogenate Prescribing Information. Bayer HealthCare LLC, Whippany, NJ. 2.

Who makes Adynovate?

Manufacturer: Baxalta US Inc.

What is a recombinate offer?

Recombinate offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

How much does recombinate cost?

The cost for Recombinate intravenous powder for injection recombinant is around $11 for a supply of 1 powder for injection, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

How much does a free drug card save?

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

OnePath support

We’ve put together some helpful information and resources below to help guide you through your journey.

OnePath Co-Pay Assistance Program

The OnePath Co-Pay Assistance Program helps eligible patients cover certain out-of-pocket treatment costs.*

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9